Recent RPRX News
- Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 02:05:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:33:43 PM
- Royalty Pharma Reports Q4 and Full Year 2023 Results • GlobeNewswire Inc. • 02/15/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 12:01:30 PM
- Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 • GlobeNewswire Inc. • 01/30/2024 09:15:00 PM
- Royalty Pharma Announces Dividend Increase • GlobeNewswire Inc. • 01/19/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:18:52 PM
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:31:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:30:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:29:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 06:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2023 09:47:54 PM
- Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference • GlobeNewswire Inc. • 11/27/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:16:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 10:13:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 12:35:11 AM
- Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program • GlobeNewswire Inc. • 11/13/2023 01:10:00 PM
- Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program • Business Wire • 11/13/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 12:40:12 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM